Literature DB >> 2930709

Determination of oestrogen receptors with monoclonal antibodies in fine needle aspirates of breast carcinoma.

A Marrazzo1, G La Bara, P Taormina, P Bazan.   

Abstract

Fifty patients with operable breast carcinoma underwent fine needle aspiration for cytological examination. The smears were prepared by means of the immunocytochemical method using monoclonal antibodies for the determination of the oestrogen receptors (ER). After surgery the contents of the ER were determined with the traditional biochemical technique. The results of the immunocytochemical method showed 31 positives, two of which disagreed with the biochemical results, 15 negatives and four cases which could not be assessed due to the absence of adequate numbers of cells. The ICA staining for ER was expressed on a semiquantitative basis; there was a significant correlation between this and the values expressed by the biochemical technique, with a coefficient of 0.83, P less than 0.000006.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930709      PMCID: PMC2247088          DOI: 10.1038/bjc.1989.86

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Estrogen receptors in human breast cancer.

Authors:  G Leclercq; J C Heuson; R Schoenfeld; W H Mattheiem; H J Tagnon
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

2.  Current use of steroid hormone receptor assays in the treatment of breast cancer.

Authors:  C K Osborne; W L McGuire
Journal:  Surg Clin North Am       Date:  1978-08       Impact factor: 2.741

3.  Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response.

Authors:  L P Pertschuk; K B Eisenberg; A C Carter; J G Feldman
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

4.  Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors:  K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal:  Arch Pathol Lab Med       Date:  1985-08       Impact factor: 5.534

5.  Monoclonal antibodies as probes for estrogen receptor detection and characterization.

Authors:  G L Greene; E V Jensen
Journal:  J Steroid Biochem       Date:  1982-03       Impact factor: 4.292

6.  [Fine-needle aspiration biopsy and analysis of estrogen receptors in breast cancer].

Authors:  B Benyahia; H Magdelenat; A Zajdela; J R Vilcoq
Journal:  Bull Cancer       Date:  1982       Impact factor: 1.276

7.  Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.

Authors:  A Shimada; S Kimura; K Abe; K Nagasaki; I Adachi; K Yamaguchi; M Suzuki; T Nakajima; L S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Pre-operative determination of oestrogen receptor status in breast cancer by immunocytochemical staining of fine needle aspirates.

Authors:  D J Crawford; A Lope-Pihie; S Cowan; W D George; R E Leake
Journal:  Br J Surg       Date:  1985-12       Impact factor: 6.939

9.  The relevance of control histology in oestrogen receptor estimation.

Authors:  R J Steele; R A Hawkins; T J Anderson; A P Forrest
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

10.  Intra-tumoural variation of oestrogen receptor status in endometrial cancer.

Authors:  L Castagnetta; M Lo Casto; T Mercadante; L Polito; S Cowan; R E Leake
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

View more
  1 in total

1.  17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters.

Authors:  T Suzuki; T Moriya; N Ariga; C Kaneko; M Kanazawa; H Sasano
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.